title: Primary central nervous system lymphoma (PCNSL) in immunocompetent adults: analysis of a retrospective series of patients treated using idarubicin-containing regimen and radiotherapy.
authors.forename: Maria Luigia
authors.initials: ML
authors.lastname: Vigliotti
authors.forename: Matteo
authors.initials: M
authors.lastname: Dell'Olio
authors.forename: Antonio
authors.initials: A
authors.lastname: La Sala
authors.forename: Giampiero
authors.initials: G
authors.lastname: Romano
authors.forename: Alfredo
authors.initials: A
authors.lastname: Tartarone
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Mele
authors.forename: Clelia
authors.initials: C
authors.lastname: Musto
authors.forename: Angelo Michele
authors.initials: AM
authors.lastname: Carella
authors.forename: Nicola
authors.initials: N
authors.lastname: Di Renzo
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy / Q000453:epidemiology* / Q000532:radiotherapy; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage / Q000493:pharmacokinetics; D007121:Immunocompetence; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000453:epidemiology / Q000532:radiotherapy / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D012074:Remission Induction; D012189:Retrospective Studies; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone; D015255:Idarubicin